Top Pharmaceutical Companies in Atlanta, GA (23)
Medspas are booming, and are often a path for individual nurses to become business owners. We believe that’s a good thing for them, their communities, local economies, and clients. We unlock the entrepreneurial opportunity in aesthetics for those with the moxie to take the leap. Moxie gives aesthetic entrepreneurs everything they need to successfully compete (and win) against even the biggest...
AlixaRx provides advanced pharmacy services to post‐acute healthcare facilities through a new model that leverages technology to deliver medication therapy management. AlixaRx is a differentiated approach because it utilizes a combination of clinical pharmacists, automated dispensing units, and electronic medication cabinets to meet the medical needs of patients and residents at each facility. AlixaRx delivers improved safety, creates better access...
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...
Roche's Top Stability & Growth Strengths
Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.
Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.
Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of patients with underserved conditions. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span...
The National MS Society is a non-profit organization dedicated to curing multiple sclerosis while empowering people affected by the disease to live their best lives through research, education, and support.
Vanigent is a fast-growing Contract Sales Organization (CSO) based in Atlanta, serving the biotechnology and pharmaceutical industries. With a leadership team averaging 25 years of life sciences experience, we deliver strategic and commercial solutions across multiple therapeutic areas while upholding the highest standards of innovation, compliance, and integrity. Our approach combines decades of field expertise with technology-driven solutions that help clients...
When you donate blood plasma, you help create life-changing medicines, while putting a little extra money in your pocket at the same time.
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing...
Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions.
Over 10 years ago, Peachtree was founded to fill a perceived missing principle in typical CRO services. Where can I find a CRO that will partner with me, understand my challenges, and solve issues to keep my program on track? Filling this need requires experienced clinical research professionals. We focused on people – building an organization by investing in highly experienced...
PHIGENIX is a leader in developing diagnostics and targeted therapies which may assist physicians in determining treatment regime. With these diagnostic tests, prostate and breast cancer patients likely to benefit maximally from a particular therapy can be identified, and other patients for whom alternative therapies (e.g. hormonal manipulation) can be selected. We accomplish this by pioneering new approaches in early...
Click here to find out how Mikart Pharmaceuticals can help you - a CDMO leader in contract pharmaceutical development, manufacturing and packaging services.
Porter Logistics is a leading Atlanta-based 3PL warehousing provider offering comprehensive third-party logistics services to brands, manufacturers, retailers, and direct sellers across many industries including Consumer Products, Food & Beverage, HAZMAT Chemical, & Cold Storage industries. With Porter Logistics, brands are able to achieve economies of scale, reduce spend, and bring omnichannel operations under one roof to drive revenue growth...
For over 240 years, Takeda’s propensity to evolve has driven the next generation of innovation, and as a future-focused organization, we’re continuing to drive forward with endurance in our steadfast pursuit to achieve the best outcomes for our patients in a rapidly changing world. We have been preparing for this period of value creation by investing in data, digital and...
Takeda's Top Stability & Growth Strengths
Strong Market Position & Advantage: Takeda is consistently placed among the global top 15–20 by revenue and is a clear category leader in GI/IBD, plasma-derived therapies, and dengue vaccines with broad international authorizations and WHO support. Subcutaneous ENTYVIO and new oncology approvals like FRUZAQLA broaden real‑world use and extend reach.
Profitability: Reported FY2025 operating profit rose 19.3% year over year and EPS nearly doubled despite a slight revenue decline, supported by lower amortization and restructuring expense. Core profitability remained broadly stable as Growth & Launch Products expanded their share.
Future-Ready Strategy: Management is investing through FY2026 to convert a late‑stage pipeline (e.g., oveporexton, rusfertide, zasocitinib) into multiple launches, with Growth & Launch Products prioritized as near‑term engines. A multi‑year transformation and efficiency program targeting significant savings by FY2028 is intended to fund launches and strengthen competitiveness.
Chemily, LLC specializes in cost-effective synthesis of glycan libraries, carbohydrate-based biochemicals, reagents and pharmaceuticals.
EngagedMedia holds the only patents in pharma that allow real-time access to claim data and discount delivery based on the data. We maintain a HIPAA & HITECH-friendly environment with all of our communications, and this allows us to communicate directly with patients throughout their journey on their prescribed, branded therapy. As strategic partners to our clients, we focus on the...
